Library

feed icon rss

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    ISSN: 1432-1440
    Keywords: Triamterene ; Pharmacokinetics ; Metabolism ; Bioavailability ; Determination ; Liver disease ; Renal disease ; Age
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Summary The knowledge about the pharmacokinetics of triamterene (TA) was limited until recently. The metabolic pathway of TA is the formation of p-hydroxytriamterene (OH-TA), which is subsequently conjugated with active sulfate to form p-hydroxytriamterene sulfuric acid ester (OH-TA-ester). The phase-II-metabolite is surprisingly pharmacologically active. TA and its metabolites were measured concomitantly by a specific and sensitive tlc-method. The i.v. kinetics of TA were determined after application of a newly developed lactic acid solution of the drug. Comparing these data with results after oral application of TA the bioavailability of TA was 52% and the extent of absorption 83%. The bioavailability of different dosage forms was correlated with in vitrotests. In liver disease the pharmacokinetics of TA are markedly altered. While in cirrhosis the hydroxylation of TA was decreased, the biliary excretion of this agent was strongly reduced in hepatitis. In renal disease the excretion of TA and OH-TA-ester was reduced proportional to the reduction of endogenous creatinine clearance. In older patients the elimination of TA was impaired.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 2
    Electronic Resource
    Electronic Resource
    Springer
    European journal of clinical pharmacology 13 (1978), S. 103-111 
    ISSN: 1432-1041
    Keywords: Digitoxin ; β-acetyldigoxin ; plasma levels ; cardiac performance ; dose-effect relationship ; 86-Rb-erythrocyte assay ; systolic time intervals
    Source: Springer Online Journal Archives 1860-2000
    Topics: Chemistry and Pharmacology , Medicine
    Notes: Summary An inter-individual, randomized, double-blind study of digitoxin (Dt) and β-acetyl digoxin (D) was performed in 120 healthy male volunteers. Groups of 10 persons each received orally D 0, 0.1, 0.2, 0.3, 0.4, 0.5 or 0.6 mg and Dt 0.04, 0.08, 0.12, or 0.16 mg daily for 7 days; Loading doses were given for the first three days. Plasma levels were measured with an86Rb-erythrocyte assay 24 h after the last dose. ECG, carotid artery pulse and phonocardiogram were recorded prior to (b) and 24 h after (a) the last dose. QTc, amplitude of T-waves in V2 to V6, electromechanical systole (QS2c) and left ventricular ejection time (LVETc) were measured. The differences between a and b (Δ-values) reflect glycoside-induced changes in heart function. The plasma glycoside concentrations depended on dose and ranged from 0 to 2.4 ng/ml for D and from 0 to 42 ng/ml for Dt. QTc, QS2c, and LVETc were significantly shortened by the glycosides and typical parallel, sigmoid, log dose-response curves were obtained for the Δ-values. Dt was 3.8-times as potent as D in diminishing these parameters. The maximal effect of the two glycosides was almost identical at the highest doses: Δ-QTc=−45 ms, Δ-QS2c=−25 ms, Δ-LVETc=−12.5 ms. The latter two parameters showed a plateau of maximum efficacy. Both glycosides caused significant flattening of T-waves, Dt being 7.2-times as potent as D. Significant relationships between plasma concentration and cardiac effects were observed (p〈0.001)−Δ-QTc (D: r=0.7; Dt: r=0.77), Δ-QS2c (D: r=0.7; Dt: r=0.75), and Δ-LVETc (D: r=0.46; Dt: r=0.43); D correlated less well than Dt with the flattening of T (r=0.46; r=0.76, respectively). The most important conclusions were that: Dt was about 4-times as potent as D in influencing cardiac performance; the effects of D and Dt on systolic time intervals reached a plateau at “therapeutic” doses; Dt induced more pronounced flattening of the T-wave than D; and plasma glycoside levels within the “therapeutic” range corresponded to observed effects on the heart.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 3
    Electronic Resource
    Electronic Resource
    Springer
    Journal of molecular medicine 61 (1983), S. 523-527 
    ISSN: 1432-1440
    Keywords: Digoxin ; Sinus node function ; Autonomic blockade
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Summary The effect of iv digoxin on normal sinus node function was studied after pharmacologic autonomic blockade (AB) in ten patients. Sinus cycle length (SCL), sinus node recovery time (SNRT) and sinoatrial conduction time (SACT) were determined before and after AB with propranolol (0.2 mg/kg body weight) and atropine sulfate (0.04 mg/kg body weight) iv, and 15 min, 30 min, and 45 min after 1 mg iv digoxin. AB resulted in a significant decrease (P〈0.01) in SCL (916±158 to 716±120 ms), in SNRT (1,229±221 to 871±190 ms), and in SACT (79±34 to 44±10 ms). Fifteen minutes after iv digoxin there was no significant change observed in SCL (716±120 to 708±92 ms), in SNRT (871±190 to 864±148 ms), or in SACT (44±10 to 46±15 ms). Similar results were obtained 30 min after digoxin administration. It is concluded that a single therapeutic dose of digoxin has no direct effect on electrophysiologic parameters of normal intrinsic sinus node function.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 4
    Electronic Resource
    Electronic Resource
    Springer
    Journal of molecular medicine 56 (1978), S. 1179-1183 
    ISSN: 1432-1440
    Keywords: Digoxin ; Digitoxin ; Intoxikation ; Hämoperfusion mit beschichteter Aktivkohle ; Hämodialyse ; Entgiftung ; Digoxin ; digitoxin ; intoxication ; activated charcoal ; hemoperfusion ; hemodialysis ; detoxification
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Description / Table of Contents: Summary Since there is no widely used causal means of reducing the severity of massive digitalis intoxication the capability of hemoperfusion with coated activated charcoal to remove toxicologically relevant amounts of digoxin and digitoxin was evaluated in vitro and in man. At a blood flow rate of 100 ml/min the digoxin clearance by hemoperfusion in vitro was 51±8 ml/min in comparison to 24.3±11.3 ml/min by hemodialysis. The average hemoperfusion clearance of digitoxin was 31.7±13.4 ml/min, whereas almost no digitoxin was removed by hemodialysis. These clearance values point to the ability of hemoperfusion of eliminating digitalis glycosides from the blood. They do not clarify the essential question whether it is possible to lower the toxic concentrations in the tissues. In two patients being on hemoperfusion for other reasons, 0.5 mg digoxin were injected intravenously as a bolus 1 h prior to the beginning of hemoperfusion and 0.125 mg/h were infused continuously over 4h simultaneously with hemoperfusion. By an average digoxin clearance of 77 ml/min, only 5 and 4.5% of the dose given were removed by this procedure. In 2 patients receiving digitoxin under the same trial conditions an average of 24% of the digitoxin load were eliminated by 4 to 6 h hemoperfusion period although the clearance values obtained were below the clearance for digoxin. The lack of effectiveness in eliminating toxicological relevant amounts of digoxin is due to the quite high distribution volume which results in high tissue concentrations and low blood concentrations of the drug. On the other hand the effective removal of digitoxin is due to the appreciably smaller distribution volume and suggests that hemoperfusion may be a valuable method of rapid reversal of advanced digitoxin toxicity in man.
    Notes: Zusammenfassung Bisher gibt es keine allgemein anwendbare kausale Therapie lebensbedrohlicher Digitalis-Intoxikationen. Daher wurde in vitro und in vivo beim Menschen untersucht, ob die Hämoperfusion mit beschichteter Aktivkohle toxikologisch relevante Mengen von Herzglykosiden zu eliminieren vermag. Bei einer Blutumlaufgeschwindigkeit von 100 ml/min betrug in vitro die Digoxin-Clearance durch Hämoperfusion 51±8 ml/min, im Vergleich zu 24,3±11,3 ml/min durch die Hämodialyse. Für Digitoxin fand sich eine Clearance von 31,7±13,4 ml/min durch Hämoperfusion, während bei Hämodialyse kein meßbarer Anteil des Glykosids eliminiert wurde. Diese Clearence-Werte lassen erwarten, daß die Herzglykoside durch die Hämoperfusion aus dem Blut eliminiert werden, ohne daß allerdings durch die in vitro-Untersuchung eine Aussage möglich ist, ob toxische Glykosidkonzentrationen im Gewebe hierdurch gesenkt werden können. Bei 2 Patienten, bei denen aus anderen Gründen eine Hämoperfusion durchgeführt wurde, wurde Digoxin nach einer Bolusinjektion von 0,5 mg mit einer konstanten Geschwindigkeit von 0,125 ml/h infundiert und der Effekt der Hämoperfusion ermittelt. Bei einer mittleren Digoxin-Clearance von 77 ml/min wurden durch eine 4- bzw. 6-stündige Hämoperfusion nur 5% und 4,5% der applizierten Dosis eliminiert. Dahingegen wurden bei gleichem Vorgehen bei 2 anderen Patienten im Mittel 24% der verabreichten Digitoxin-Dosis durch eine 4- bzw. 6stündige Hämoperfusion eliminiert, obwohl die Digitoxin-Clearance deutlich unter der Digoxin-Clearance lag. Die geringe Effektivität der Hämoperfusion bei der Digoxinelimination ist auf das große Verteilungsvolumen dieses Glykosids zurückzuführen, welches durch hohe Gewebe-und niedrige Plasmakonzentrationen gekennzeichnet ist. Andererseits ist die gute Wirkung der Hämoperfusion in der Elimination von Digitoxin auf das deutlich kleinere Verteilungsvolumen zurückzuführen und läßt den Einsatz der Hämoperfusion bei lebensbedrohlicher Digitoxin-Intoxikation sinnvoll erscheinen.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...